Scientific American Worldview: A Global Biotechnology Perspective has launched its eighth annual scorecard at the BIO International Convention in San Francisco, confirming Australia has held its place in the top five countries for the third consecutive year.
The Report said: “It might be down under geographically, but Australia finished in the scorecard’s top five for the past three years. It also produced the 12th highest output on the Nature Index 2015 Global.”
AusBiotech’s attraction of industry-building conferences was noted in the report: “Experts around the world recognise the biotechnology opportunities in this country, as some events demonstrate. In October 2016, for example, Australia will host BioFest 2016, which is billed as ‘the largest-ever gathering in Australian life sciences, with three major conferences coming together in one week in one place as one integrated network.’”
Australia ranked fifth this year, measured by IP protection, intensity (ranked #3), enterprise support, workforce/education (ranked #4), productivity (ranked #2), policy and stability. Australia also ranked in the global top three on four indicators:
#3 Greatest public company revenues;
#2 Most public companies;
#2 Most public company employees; and
#2 Largest biotech public markets.
The full report can be found at the Scientific American Worldview website.